Home > Name List By 4 > 4-(3-cyclopentyloxy-4-methoxyphenyl)pyrrolidin-2-one Switzerland

CAS No 61413-54-5 , 4-(3-cyclopentyloxy-4-methoxyphenyl)pyrrolidin-2-one Search by region : Switzerland

  • Name: 4-(3-cyclopentyloxy-4-methoxyphenyl)pyrrolidin-2-one
  • Synonyms: ZK 62711;Rolipramum [Latin]; 4-[3-(Cyclopentyloxy)-4-methoxyphenyl]-2-pyrrolidinone; Adeo;4-(3-cyclopentyloxy-4-methoxyphenyl)pyrrolidin-2-one; ZK-62711; 61413-54-5;
  • CAS Registry Number:
  • Transport: 3249
  • Melting Point: 127-133 °C
  • Density: 1.155 g/cm3
  • Refractive index: 1.552
  • Water Solubility: H2O: 0.2 mg/mL
  • Safety Statements: 26-36
  • Hazard Symbols: Xi
  • EINECS: 262-771-1
  • Molecular Weight: 275.34284
  • InchiKey: HJORMJIFDVBMOB-UHFFFAOYSA-N
  • InChI: InChI=1S/C16H21NO3/c1-19-14-7-6-11(12-9-16(18)17-10-12)8-15(14)20-13-4-
    2-3-5-13/h6-8,12-13H,2-5,9-10H2,1H3,(H,17,18)
  • Risk Statements: 36/37/38
  • Molecular Formula: C16H21NO3
  • Molecular Structure:CAS No:61413-54-5 4-(3-cyclopentyloxy-4-methoxyphenyl)pyrrolidin-2-one

Related products

Select to

61413-54-5 ROLIPRAM

  • Switzerland BIOTREND Chemicals AG [Manufacturer]
  • Tel: +41 44 805 76 76
  • Fax: +41 44 805 76 77
  • Address: BIOTREND Chemicals AG
    Unterdorfstr. 21b
    CH-8602 Wangen/Zuerich
    Switzerland null,nullSwitzerland
Contact Supplier

Select to

1/1
References of 4-(3-cyclopentyloxy-4-methoxyphenyl)pyrrolidin-2-one
Title: Rolipram
CAS Registry Number: 61413-54-5
CAS Name: 4-[3-(Cyclopentyloxy)-4-methoxyphenyl]-2-pyrrolidinone
Manufacturers' Codes: ZK-62711
Molecular Formula: C16H21NO3
Molecular Weight: 275.34
Percent Composition: C 69.79%, H 7.69%, N 5.09%, O 17.43%
Literature References: Prototypical selective phosphodiesterase 4 (PDE4) inhibitor. Prepn: BE 826923; R. Schmiechen et al., US 4193926 (1975, 1980 both to Schering AG). Selective enzyme inhibition and enhancement of cAMP accumulation in rat brain tissue: U. Schwabe et al., Mol. Pharmacol. 12, 900 (1976). Antidepressant mechanism of action study: H. Wachtel, Neuropharmacology 22, 267 (1983). Receptor binding study: H. H. Schneider et al., Eur. J. Pharmacol. 127, 105 (1986). Pharmacokinetics: W. Krause, G. Kühne, Xenobiotica 18, 561 (1988). Clinical evaluation in severe depression: F. Eckmann et al., Curr. Ther. Res. 43, 291 (1988). Pharmacology and efficacy in exptl autoimmune encephalomyelitis: N. Sommer et al., Nat. Med. 1, 244 (1995).
Properties: Crystals from ethyl acetate, mp 132°.
Melting point: mp 132°
Use: Pharmacological tool for characterization of phosphodiesterase isoenzymes.
Therap-Cat: Antidepressant.